| Literature DB >> 30070983 |
Maureen Martinez, Hemant Shukla, Maiwand Ahmadzai, Joanna Nikulin, Mufti Zubair Wadood, Jamal Ahmed, Chukwuma Mbaeyi, Jaume Jorba, Derek Ehrhardt.
Abstract
Afghanistan, Pakistan, and Nigeria remain the only countries where transmission of endemic wild poliovirus type 1 (WPV1) continues (1). This report describes polio eradication activities, progress, and challenges to eradication in Afghanistan during January 2017-May 2018 and updates previous reports (2, 3). Fourteen WPV1 cases were confirmed in Afghanistan in 2017, compared with 13 in 2016; during January-May 2018, eight WPV1 cases were reported, twice the number reported during January-May 2017. To supplement surveillance for acute flaccid paralysis (AFP) and laboratory testing of stool samples, environmental surveillance (testing of sewage samples) was initiated in 2013 and includes 20 sites, 15 of which have detected WPV1 circulation. The number of polio-affected districts increased from six in 2016 to 14 in 2017 (including WPV1 cases and positive environmental samples). Access to children for supplementary immunization activities (SIAs) (mass campaigns targeting children aged <5 years with oral poliovirus vaccine [OPV], regardless of vaccination history), which improved during 2016 to early 2018, worsened in May 2018 in security-challenged areas of the southern and eastern regions. To achieve WPV1 eradication, measures to maintain and regain access for SIAs in security-challenged areas, strengthen oversight of SIAs in accessible areas to reduce the number of missed children, and coordinate with authorities in Pakistan to track and vaccinate mobile populations at high risk in their shared transit corridors must continue.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30070983 PMCID: PMC6072060 DOI: 10.15585/mmwr.mm6730a6
Source DB: PubMed Journal: MMWR Morb Mortal Wkly Rep ISSN: 0149-2195 Impact factor: 17.586
Acute flaccid paralysis (AFP) surveillance indicators and reported cases of wild poliovirus (WPV), by region and period — Afghanistan, January 2017–May 2018*
| Region of Afghanistan | AFP surveillance indicators (2017) | No. of WPV cases reported | ||||
|---|---|---|---|---|---|---|
| No. of AFP cases | Rate of nonpolio AFP† | % of AFP cases with adequate specimens§ | Jan–Jun 2017 | Jul–Dec 2017 | Jan–May 2018 | |
|
|
|
|
|
|
|
|
| Badakhshan | 65 | 11.4 | 95.4 | 0 | 0 | 0 |
| Northern | 345 | 13.7 | 92.8 | 0 | 0 | 0 |
| Northeastern | 421 | 18.7 | 91.9 | 1 | 0 | 0 |
| Central | 545 | 11.8 | 96.9 | 0 | 0 | 0 |
| Eastern | 363 | 18.3 | 93.9 | 0 | 3 | 3 |
| Southeastern | 250 | 12.7 | 94.8 | 0 | 0 | 0 |
| Southern | 543 | 15.4 | 87.5 | 4 | 6 | 5 |
| Western | 546 | 20.4 | 95.1 | 0 | 0 | 0 |
* Data current through May 15, 2018.
† Per 100,000 persons aged <15 years. Surveillance target is ≥2/100,000 persons aged <15 years.
§ Surveillance target is that ≥80% of AFP cases have adequate stool specimens collected. Adequate stool specimens are defined as two stool specimens of sufficient quality for laboratory analysis, collected ≥24 hours apart, both within 14 days of paralysis onset, and arriving in good condition at a World Health Organization–accredited laboratory with reverse cold chain maintained and without leakage or desiccation and with proper documentation.
FIGURE 1Number of wild poliovirus type 1 (WPV1) cases (n = 83) — Afghanistan, January 2014–May 2018
FIGURE 2Cases of wild poliovirus type 1 (WPV1),* by province — Afghanistan, January 2017–May 2018
* Each dot represents one case. Dots are randomly placed within provinces.